Prestige Consumer Healthcare Inc. Stock
Prestige Consumer Healthcare Inc. shows a slight decrease today, losing -€0.500 (-0.760%) compared to yesterday.
Our community is currently high on Prestige Consumer Healthcare Inc. with 4 Buy predictions and 0 Sell predictions.
As a result the target price of 107 € shows a very positive potential of 64.62% compared to the current price of 65.0 € for Prestige Consumer Healthcare Inc..
Pros and Cons of Prestige Consumer Healthcare Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
S********** s********
Cons
?
M***** P*******
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Prestige Consumer Healthcare Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Prestige Consumer Healthcare Inc. | -0.760% | 0.000% | 0.775% | 18.182% | 17.117% | 64.975% | 144.729% |
Apollo Medical Holdings, Inc. | 2.810% | 3.390% | 1.105% | 18.831% | 2.235% | - | - |
Petmed Express Inc | 1.210% | 7.412% | 7.384% | -70.144% | -38.838% | -82.287% | - |
Ingles Markets Inc | 1.500% | 1.504% | -0.735% | -9.396% | -12.338% | 31.068% | - |
Comments
Prestige Consumer Healthcare Inc. (NYSE: PBH) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for PBH provided by MarketBeat
Prestige Consumer Healthcare Inc. (NYSE: PBH) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for PBH provided by MarketBeat
Prestige Consumer Healthcare Inc. (NYSE: PBH) had its price target lowered by analysts at BMO Capital Markets from $124.00 to $117.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for PBH provided by MarketBeat